ALKEM - Swing Trade Analysis with AI Signals

Last Updated Time : 19 Sept 25, 2:15 pm

Swing Trade Rating: 4.1

📊 Technical & Momentum Analysis

Price vs DMA: Trading well above both 50-DMA (₹5,224) and 200-DMA (₹5,133), confirming strong short-term momentum and trend continuation.

RSI (66.8): Bullish zone, nearing overbought—momentum is strong but watch for exhaustion.

MACD (84.7): Strong positive crossover—momentum confirmation is solid.

Volume: Above 1-week average, indicating healthy participation and breakout strength.

📈 Fundamental Snapshot

Metric Value Interpretation

P/E 30.4 Slightly undervalued vs industry PE (33.4) — valuation support

PEG Ratio 2.18 Overpriced relative to growth — valuation caution

ROCE / ROE 19.5% / 19.9% Strong capital efficiency — supports quality setup

Debt-to-Equity 0.04 Virtually debt-free — low financial risk

PAT Growth (QoQ) +170% Massive earnings surge — sentiment driver

FII/DII Change -0.29% / +2.38% Strong DII accumulation offsets mild FII trimming — net positive

🧠 Swing Trade Logic

Bias: Bullish momentum setup with strong fundamentals and breakout confirmation.

Catalyst: MACD strength + ROCE/ROE excellence + DII accumulation.

Risk: RSI nearing overbought and elevated PEG — tight stop-loss recommended.

🎯 Optimal Entry Price

Buy Zone: ₹5,400–₹5,450

(Pullback toward 50-DMA with stop-loss below ₹5,300)

🚪 Exit Strategy

If Already Holding

Target Exit: ₹5,750–₹5,850 (Resistance zone from prior swing highs)

Stop-Loss: ₹5,300 (Below 200-DMA and MACD base)

Selva, this setup fits well into a momentum basket with valuation discipline and efficiency strength. If you're expanding your pharma rotation, I can scan for peers with similar ROCE overlays and breakout triggers. Let’s build that next layer when you're ready.

Edit in a page